Aiba K - Search Results

1

Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drug.

Hirata K, Horikoshi N, Aiba K, Okazaki M, Denno R, Sasaki K, Nakano Y, Ishizuka H, Yamada Y, Uno S, Taguchi T, Shirasaka T. Hirata K, et al. Among authors: aiba k. Clin Cancer Res. 1999 Aug;5(8):2000-5. Clin Cancer Res. 1999. PMID: 10473078 Clinical Trial.

2

[Phase I and pharmacokinetic study of SM-5887 by 5-day schedule].

Inoue K, Matsumura A, Horikoshi N, Aiba K, Mukaiyama T, Matsumura T, Ogihara A, Sumida T, Ogawa M. Inoue K, et al. Among authors: aiba k. Gan To Kagaku Ryoho. 1992 Apr;19(4):477-82. Gan To Kagaku Ryoho. 1992. PMID: 1558397 Japanese.

3

[Estimation of pathways of 5-fluorouracil anabolism in human cancer cells in vitro and in vivo].

Fukushima M, Nomura H, Murakami Y, Shirasaka T, Aiba K. Fukushima M, et al. Among authors: aiba k. Gan To Kagaku Ryoho. 1996 May;23(6):721-31. Gan To Kagaku Ryoho. 1996. PMID: 8645024 Japanese.

4

Phase I dose-escalation trial of ZD9331 in Japanese patients with refractory, solid malignancies.

Koizumi W, Aiba K, Sasaki T, Sato A, Horikoshi N. Koizumi W, et al. Among authors: aiba k. Anticancer Drugs. 2003 May;14 Suppl 1:S1-5. doi: 10.1097/00001813-200305001-00001. Anticancer Drugs. 2003. PMID: 14567434 Clinical Trial.

5

Phase I and pharmacokinetic study of KW-2170, a novel pyrazoloacridone compound, in patients with malignant tumors.

Saeki T, Eguchi K, Takashima S, Sugiura T, Hida T, Horikoshi N, Aiba K, Kuwabara T, Ogawa M. Saeki T, et al. Among authors: aiba k. Cancer Chemother Pharmacol. 2004 Nov;54(5):459-68. doi: 10.1007/s00280-004-0808-z. Cancer Chemother Pharmacol. 2004. PMID: 15290094 Clinical Trial.

6

[Current status of low-dose CDDP. 5-FU therapy for solid malignant tumors--nationwide questionnaire survey].

Saji S, Aiba K, Araki H, Sasaki K, Shirasaka T, Sowa M, Tanaka M, Chung Y, Toge T, Hirata K, Yasumoto K, Yamamitsu S, Wada H. Saji S, et al. Among authors: aiba k. Gan To Kagaku Ryoho. 1997 Oct;24(13):1892-900. Gan To Kagaku Ryoho. 1997. PMID: 9350233 Clinical Trial. Japanese.

7

[Combination therapy of continuous venous infusion (CVI) of 5-FU and low dose consecutive cisplatin (CDDP), and the new oral anti-cancer drug S-1 for advanced gastro-intestinal cancer].

Shirasaka T, Aiba K, Araki H, Suzuki M, Terashima M, Mikami Y. Shirasaka T, et al. Among authors: aiba k. Gan To Kagaku Ryoho. 1999 Mar;26(4):456-66. Gan To Kagaku Ryoho. 1999. PMID: 10097742 Review. Japanese.

8

[Oral cancer chemotherapy in the clinic].

Horikoshi N, Saotome T, Yoshida N, Aiba K. Horikoshi N, et al. Among authors: aiba k. Gan To Kagaku Ryoho. 2000 Oct;27(11):1641-6. Gan To Kagaku Ryoho. 2000. PMID: 11057313 Review. Japanese.

9

Phase II study of raltitrexed (Tomudex) in chemotherapy-pretreated patients with advanced colorectal cancer. Tomudex Cooperative Study Group.

Sato A, Kurihara M, Horikoshi N, Aiba K, Kikkawa N, Shirouzu K, Mitachi Y, Sakata Y, Wakui A. Sato A, et al. Among authors: aiba k. Anticancer Drugs. 1999 Sep;10(8):741-8. doi: 10.1097/00001813-199909000-00008. Anticancer Drugs. 1999. PMID: 10573207 Clinical Trial.

10

Pilot study of continuous low-dose 5-fluorouracil and cisplatin (FP regimen) for the treatment of metastatic breast cancer.

Yamada Y, Aiba K, Horikosi N, Hanai M, Uno S, Osawa H, Mizunuma N, Takahashi S, Ito Y. Yamada Y, et al. Among authors: aiba k. Int J Clin Oncol. 2000 Feb;5(1):18-21. doi: 10.1007/s101470050004. Int J Clin Oncol. 2000. PMID: 20563692

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters